XML 36 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
Pay Versus Performance
We are providing the following information about the relationship between “compensation actually paid” to our named executive officers and certain financial performance as required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation
S-K.
Please see the Compensation Discussion and Analysis on page 41 for additional information regarding our executive compensation program.
 
PAY VERSUS PERFORMANCE(1)
  
                 
Year
(a)
  
 Summary 
Compen-
sation
Table
(“SCT”)
Total for
PEO
(Carestio)
(b)
    
  SCT Total for  
PEO
(Rosebrough)
(b)
    
 Compensation 
Actually Paid
to PEO

(Carestio)
(c)(2)
    
 Compensation 
Actually Paid
to PEO

(Rosebrough)
(c)(2)
    
Average
 SCT Total 
for
Non-PEO

Named
Executive
Officers
(d)
    
Average
Compen-
sation
Actually
Paid to
Non-PEO

Named
 Executive 
Officers
(e)(2)
    
Value of Initial
Fixed $100
 Investment Based 
On:
    
Net
Income –
in
 thousands 
(h)(5)
    
EBIT – in
 thousands 
(i)(6)
  
 
Total
Share-
holder
Return
(f)(3)
    
Peer
Group
Total
Share-
holder
Return
(g)(4)
  
2024 
   $ 9,550,776       —     $ 14,143,349       —     $ 2,468,192     $ 3,588,373     $ 171.77     $ 211.63     $ 378,239     $ 1,270,423  
2023 
   $ 7,740,184       —     $ 2,167,818       —     $ 2,053,642     $ 15,524     $ 144.07     $ 176.92     $ 107,030     $ 1,170,001  
2022 
   $ 5,903,168     $ 1,156,398     $ 11,823,596     $ 9,584,917     $ 2,354,427     $ 5,031,228     $ 178.09     $ 183.84     $ 243,888     $ 1,076,769  
2021 
     —     $ 6,847,109       —     $ 20,016,406     $ 2,336,554     $ 5,591,256     $ 138.50     $ 167.11     $ 397,400     $ 699,380  
 
(1)
Daniel A. Carestio was our principal executive officer (“PEO”) for the full year for fiscal 2024 and 2023 and from July 29, 2021 through the end of fiscal year 2022. Walter M Rosebrough, Jr. was our PEO for the full year for fiscal 2021 and from the beginning of fiscal year 2022 until July 29, 2021. For fiscal year 2024 and 2023, our
non-PEO
named executive officers were Michael J. Tokich, J. Adam Zangerle, Cary L. Majors and Mary Clare Fraser. For fiscal 2022, our
non-PEO
named executive officers were Michael J. Tokich, J. Adam Zangerle, Cary L. Majors and Andrew Xilas. For fiscal year 2021, our
non-PEO
named executive officers were Daniel A. Carestio, Michael J. Tokich, J. Adam Zangerle and Cary L. Majors.
 
(2)
For each of fiscal 2024, 2023, 2022 and 2021 (each, a “Covered Year”), in determining both the “compensation actually paid” to our PEOs and the average “compensation actually paid” to our non-PEO named executive officers for purposes of this Pay Versus Performance table (“PVP Table”), we deducted from or added to the total amounts of compensation reported in columns (b) and (d) for such Covered Year the following amounts:
 
       
Item and Value Added (Deducted)
  
2024
    
2023
    
2022
    
2021
  
For Daniel A. Carestio (as PEO)
        
- SCT “Stock Awards” column value
  
$
(2,584,412
) 
  
$
(2,154,084
) 
  
$
(1,397,772
) 
  
 
—
 
- SCT “Option Awards” column value
  
$
(4,800,238
) 
  
$
(4,000,598
) 
  
$
(2,870,787
) 
  
 
—
 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
$
9,135,555
 
  
$
4,709,722
 
  
$
7,347,026
 
  
 
—
 
+/- change in fair value of outstanding equity awards granted in prior years
  
$
2,094,239
 
  
$
(3,235,090
) 
  
$
2,796,409
 
  
 
—
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
$
696,910
 
  
$
(950,771
) 
  
$
12,373
 
  
 
—
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
$
50,518
 
  
$
58,455
 
  
$
33,179
 
  
 
—
 
TOTAL ADDED (DEDUCTED):
  
$
4,592,573
 
  
$
(5,572,366
) 
  
$
5,920,428
 
  
 
—
 
For Walter M Rosebrough, Jr. (as PEO)
 
  
- SCT “Stock Awards” column value
  
 
—
 
  
 
—
 
  
 
—
 
  
$
(1,468,984
) 
- SCT “Option Awards” column value
  
 
—
 
  
 
—
 
  
 
—
 
  
$
(2,729,173
) 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
$
6,017,324
 
+/- change in fair value of outstanding equity awards granted in prior years
  
 
—
 
  
 
—
 
  
$
8,482,009
 
  
$
8,273,815
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
 
—
 
  
 
—
 
  
$
(87,822
) 
  
$
3,032,925
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
 
—
 
  
 
—
 
  
$
34,333
 
  
$
43,391
 
TOTAL ADDED (DEDUCTED):
  
 
—
 
  
 
—
 
  
$
8,428,519
 
  
$
13,169,297
 
For
Non-PEO
Named Executive Officers (Average):
        
- SCT “Stock Awards” column value
  
$
(617,907
) 
  
$
(557,389
) 
  
$
(527,733
) 
  
$
(508,049
) 
- SCT “Option Awards” column value
  
$
(1,096,527
) 
  
$
(814,151
) 
  
$
(843,644
) 
  
$
(711,762
) 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
$
1,988,028
 
  
$
1,058,610
 
  
$
2,282,600
 
  
$
1,712,974
 
+/- change in fair value of outstanding equity awards granted in prior years
  
$
644,655
 
  
$
(1,380,326
) 
  
$
1,754,107
 
  
$
2,185,114
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
$
182,705
 
  
$
(365,275
) 
  
$
(5,442
) 
  
$
551,610
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
$
19,277
 
  
$
20,412
 
  
$
16,913
 
  
$
24,815
 
TOTAL ADDED (DEDUCTED):
  
$
1,120,181
 
  
$
(2,038,118
) 
  
$
2,676,802
 
  
$
3,254,702
 
 
 
 
(3)
For each Covered Year, our total shareholder return was calculated as the yearly percentage change in our cumulative total shareholder return
on
our Ordinary Shares measured as the quotient of (a) the sum of (i) the cumulative amount of dividends for the period beginning with our closing price on NYSE on March 31, 2020 through and including the last day of the Covered Year (each
one-year,
two-year
and three-year period, a “Measurement Period”), assuming dividend reinvestment, plus (ii) the difference between our closing stock price at the end versus the beginning of the Measurement Period divided by (b) our closing share price at the beginning of the Measurement Period. Each of these yearly percentage changes was then applied to a deemed fixed investment of $100 at the beginning of the Measurement Period to produce the Covered
Year-end
values of such investment as of the end of fiscal 2024, 2023, 2022 and 2021, as applicable. Because Covered Years are presented in the table in reverse chronical order (from top to bottom), the table should be read from bottom to top for purposes of understanding cumulative returns over time.
 
(4)
For purposes of this Pay Versus Performance disclosure, our peer group is the Dow Jones U.S. Medical Supplies Index
(the “PVP Peer Group”). For each Covered Year, the PVP Peer Group cumulative total shareholder return was calculated based on a deemed fixed investment of $100 in the index through each Measurement Period, assuming dividend reinvestment for
the PVP Peer Group
.
 
(5)
Net income is calculated in accordance with U.S. GAAP.
 
(6)
EBIT is a non-GAAP measure calculated as earnings before interest and taxes, excluding the effects of amounts related to certain special items, as described in the Compensation Discussion and Analysis. The financial metric is used in the determination of attainment percentages under our annual MICP plan. See the section in the Compensation Discussion and Analysis above titled “2024 Compensation Decisions” for more information.
     
Company Selected Measure Name EBIT      
Named Executive Officers, Footnote
(1)
Daniel A. Carestio was our principal executive officer (“PEO”) for the full year for fiscal 2024 and 2023 and from July 29, 2021 through the end of fiscal year 2022. Walter M Rosebrough, Jr. was our PEO for the full year for fiscal 2021 and from the beginning of fiscal year 2022 until July 29, 2021. For fiscal year 2024 and 2023, our
non-PEO
named executive officers were Michael J. Tokich, J. Adam Zangerle, Cary L. Majors and Mary Clare Fraser. For fiscal 2022, our
non-PEO
named executive officers were Michael J. Tokich, J. Adam Zangerle, Cary L. Majors and Andrew Xilas. For fiscal year 2021, our
non-PEO
named executive officers were Daniel A. Carestio, Michael J. Tokich, J. Adam Zangerle and Cary L. Majors.
     
Peer Group Issuers, Footnote For purposes of this Pay Versus Performance disclosure, our peer group is the Dow Jones U.S. Medical Supplies Index
(the “PVP Peer Group”). For each Covered Year, the PVP Peer Group cumulative total shareholder return was calculated based on a deemed fixed investment of $100 in the index through each Measurement Period, assuming dividend reinvestment for
the PVP Peer Group
.
      
Adjustment To PEO Compensation, Footnote
(2)
For each of fiscal 2024, 2023, 2022 and 2021 (each, a “Covered Year”), in determining both the “compensation actually paid” to our PEOs and the average “compensation actually paid” to our non-PEO named executive officers for purposes of this Pay Versus Performance table (“PVP Table”), we deducted from or added to the total amounts of compensation reported in columns (b) and (d) for such Covered Year the following amounts:
 
       
Item and Value Added (Deducted)
  
2024
    
2023
    
2022
    
2021
  
For Daniel A. Carestio (as PEO)
        
- SCT “Stock Awards” column value
  
$
(2,584,412
) 
  
$
(2,154,084
) 
  
$
(1,397,772
) 
  
 
—
 
- SCT “Option Awards” column value
  
$
(4,800,238
) 
  
$
(4,000,598
) 
  
$
(2,870,787
) 
  
 
—
 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
$
9,135,555
 
  
$
4,709,722
 
  
$
7,347,026
 
  
 
—
 
+/- change in fair value of outstanding equity awards granted in prior years
  
$
2,094,239
 
  
$
(3,235,090
) 
  
$
2,796,409
 
  
 
—
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
$
696,910
 
  
$
(950,771
) 
  
$
12,373
 
  
 
—
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
$
50,518
 
  
$
58,455
 
  
$
33,179
 
  
 
—
 
TOTAL ADDED (DEDUCTED):
  
$
4,592,573
 
  
$
(5,572,366
) 
  
$
5,920,428
 
  
 
—
 
For Walter M Rosebrough, Jr. (as PEO)
 
  
- SCT “Stock Awards” column value
  
 
—
 
  
 
—
 
  
 
—
 
  
$
(1,468,984
) 
- SCT “Option Awards” column value
  
 
—
 
  
 
—
 
  
 
—
 
  
$
(2,729,173
) 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
$
6,017,324
 
+/- change in fair value of outstanding equity awards granted in prior years
  
 
—
 
  
 
—
 
  
$
8,482,009
 
  
$
8,273,815
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
 
—
 
  
 
—
 
  
$
(87,822
) 
  
$
3,032,925
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
 
—
 
  
 
—
 
  
$
34,333
 
  
$
43,391
 
TOTAL ADDED (DEDUCTED):
  
 
—
 
  
 
—
 
  
$
8,428,519
 
  
$
13,169,297
 
For
Non-PEO
Named Executive Officers (Average):
        
- SCT “Stock Awards” column value
  
$
(617,907
) 
  
$
(557,389
) 
  
$
(527,733
) 
  
$
(508,049
) 
- SCT “Option Awards” column value
  
$
(1,096,527
) 
  
$
(814,151
) 
  
$
(843,644
) 
  
$
(711,762
) 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
$
1,988,028
 
  
$
1,058,610
 
  
$
2,282,600
 
  
$
1,712,974
 
+/- change in fair value of outstanding equity awards granted in prior years
  
$
644,655
 
  
$
(1,380,326
) 
  
$
1,754,107
 
  
$
2,185,114
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
$
182,705
 
  
$
(365,275
) 
  
$
(5,442
) 
  
$
551,610
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
$
19,277
 
  
$
20,412
 
  
$
16,913
 
  
$
24,815
 
TOTAL ADDED (DEDUCTED):
  
$
1,120,181
 
  
$
(2,038,118
) 
  
$
2,676,802
 
  
$
3,254,702
 
      
Non-PEO NEO Average Total Compensation Amount $ 2,468,192 $ 2,053,642 $ 2,354,427 $ 2,336,554
Non-PEO NEO Average Compensation Actually Paid Amount $ 3,588,373 15,524 5,031,228 5,591,256
Adjustment to Non-PEO NEO Compensation Footnote
(2)
For each of fiscal 2024, 2023, 2022 and 2021 (each, a “Covered Year”), in determining both the “compensation actually paid” to our PEOs and the average “compensation actually paid” to our non-PEO named executive officers for purposes of this Pay Versus Performance table (“PVP Table”), we deducted from or added to the total amounts of compensation reported in columns (b) and (d) for such Covered Year the following amounts:
 
       
Item and Value Added (Deducted)
  
2024
    
2023
    
2022
    
2021
  
For Daniel A. Carestio (as PEO)
        
- SCT “Stock Awards” column value
  
$
(2,584,412
) 
  
$
(2,154,084
) 
  
$
(1,397,772
) 
  
 
—
 
- SCT “Option Awards” column value
  
$
(4,800,238
) 
  
$
(4,000,598
) 
  
$
(2,870,787
) 
  
 
—
 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
$
9,135,555
 
  
$
4,709,722
 
  
$
7,347,026
 
  
 
—
 
+/- change in fair value of outstanding equity awards granted in prior years
  
$
2,094,239
 
  
$
(3,235,090
) 
  
$
2,796,409
 
  
 
—
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
$
696,910
 
  
$
(950,771
) 
  
$
12,373
 
  
 
—
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
$
50,518
 
  
$
58,455
 
  
$
33,179
 
  
 
—
 
TOTAL ADDED (DEDUCTED):
  
$
4,592,573
 
  
$
(5,572,366
) 
  
$
5,920,428
 
  
 
—
 
For Walter M Rosebrough, Jr. (as PEO)
 
  
- SCT “Stock Awards” column value
  
 
—
 
  
 
—
 
  
 
—
 
  
$
(1,468,984
) 
- SCT “Option Awards” column value
  
 
—
 
  
 
—
 
  
 
—
 
  
$
(2,729,173
) 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
$
6,017,324
 
+/- change in fair value of outstanding equity awards granted in prior years
  
 
—
 
  
 
—
 
  
$
8,482,009
 
  
$
8,273,815
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
 
—
 
  
 
—
 
  
$
(87,822
) 
  
$
3,032,925
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
 
—
 
  
 
—
 
  
$
34,333
 
  
$
43,391
 
TOTAL ADDED (DEDUCTED):
  
 
—
 
  
 
—
 
  
$
8,428,519
 
  
$
13,169,297
 
For
Non-PEO
Named Executive Officers (Average):
        
- SCT “Stock Awards” column value
  
$
(617,907
) 
  
$
(557,389
) 
  
$
(527,733
) 
  
$
(508,049
) 
- SCT “Option Awards” column value
  
$
(1,096,527
) 
  
$
(814,151
) 
  
$
(843,644
) 
  
$
(711,762
) 
+
year-end
fair value of outstanding equity awards granted in Covered Year
  
$
1,988,028
 
  
$
1,058,610
 
  
$
2,282,600
 
  
$
1,712,974
 
+/- change in fair value of outstanding equity awards granted in prior years
  
$
644,655
 
  
$
(1,380,326
) 
  
$
1,754,107
 
  
$
2,185,114
 
+ vesting date fair value of equity awards granted and vested in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+/- change in fair value of prior-year equity awards vested in Covered Year
  
$
182,705
 
  
$
(365,275
) 
  
$
(5,442
) 
  
$
551,610
 
- prior
year-end
fair value of prior-year equity awards forfeited in Covered Year
  
 
—
 
  
 
—
 
  
 
—
 
  
 
—
 
+ includable dividends/earnings on equity awards during Covered Year
  
$
19,277
 
  
$
20,412
 
  
$
16,913
 
  
$
24,815
 
TOTAL ADDED (DEDUCTED):
  
$
1,120,181
 
  
$
(2,038,118
) 
  
$
2,676,802
 
  
$
3,254,702
 
      
Compensation Actually Paid vs. Total Shareholder Return
     
Compensation Actually Paid vs. Net Income
     
Compensation Actually Paid vs. Company Selected Measure
     
Total Shareholder Return Vs Peer Group
     
Tabular List, Table
Fiscal 2024 Tabular List
The following table lists all of the financial performance measures that we used to link compensation actually
paid
to our named executive officers for
fiscal
2024 to our performance.
 
Financial Performance Measure:
EBIT
Free Cash Flow
      
Total Shareholder Return Amount $ 171.77 144.07 178.09 138.5
Peer Group Total Shareholder Return Amount 211.63 176.92 183.84 167.11
Net Income (Loss) $ 378,239,000 $ 107,030,000 $ 243,888,000 $ 397,400,000
Company Selected Measure Amount 1,270,423,000 1,170,001,000 1,076,769,000 699,380,000
Measure:: 1        
Pay vs Performance Disclosure        
Name EBIT      
Non-GAAP Measure Description EBIT is a non-GAAP measure calculated as earnings before interest and taxes, excluding the effects of amounts related to certain special items, as described in the Compensation Discussion and Analysis. The financial metric is used in the determination of attainment percentages under our annual MICP plan. See the section in the Compensation Discussion and Analysis above titled “2024 Compensation Decisions” for more information.      
Measure:: 2        
Pay vs Performance Disclosure        
Name Free Cash Flow      
Daniel J. Carestio [Member]        
Pay vs Performance Disclosure        
PEO Total Compensation Amount $ 9,550,776 $ 7,740,184 $ 5,903,168  
PEO Actually Paid Compensation Amount $ 14,143,349 2,167,818 11,823,596  
PEO Name Daniel A. Carestio      
Walter M Rosebrough, Jr. [Member]        
Pay vs Performance Disclosure        
PEO Total Compensation Amount     1,156,398 $ 6,847,109
PEO Actually Paid Compensation Amount     9,584,917 20,016,406
PEO Name Walter M Rosebrough, Jr.      
PEO | Daniel J. Carestio [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 4,592,573 (5,572,366) 5,920,428  
PEO | Daniel J. Carestio [Member] | Stock Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (2,584,412) (2,154,084) (1,397,772)  
PEO | Daniel J. Carestio [Member] | Option Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (4,800,238) (4,000,598) (2,870,787)  
PEO | Daniel J. Carestio [Member] | Year End Fair Value Of Outstanding Equity Awards Granted In Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 9,135,555 4,709,722 7,347,026  
PEO | Daniel J. Carestio [Member] | Change In Fair Value of Outstanding Equity Awards Granted In Prior Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,094,239 (3,235,090) 2,796,409  
PEO | Daniel J. Carestio [Member] | Change In Fair Value Of PriorYear Equity Awards Vested In Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 696,910 (950,771) 12,373  
PEO | Daniel J. Carestio [Member] | Includable Dividends Earnings On Equity Awards During Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 50,518 58,455 33,179  
PEO | Walter M Rosebrough, Jr. [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount     8,428,519 13,169,297
PEO | Walter M Rosebrough, Jr. [Member] | Stock Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount       (1,468,984)
PEO | Walter M Rosebrough, Jr. [Member] | Option Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount       (2,729,173)
PEO | Walter M Rosebrough, Jr. [Member] | Year End Fair Value Of Outstanding Equity Awards Granted In Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount       6,017,324
PEO | Walter M Rosebrough, Jr. [Member] | Change In Fair Value of Outstanding Equity Awards Granted In Prior Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount     8,482,009 8,273,815
PEO | Walter M Rosebrough, Jr. [Member] | Change In Fair Value Of PriorYear Equity Awards Vested In Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount     (87,822) 3,032,925
PEO | Walter M Rosebrough, Jr. [Member] | Includable Dividends Earnings On Equity Awards During Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount     34,333 43,391
Non-PEO NEO        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,120,181 (2,038,118) 2,676,802 3,254,702
Non-PEO NEO | Stock Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (617,907) (557,389) (527,733) (508,049)
Non-PEO NEO | Option Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (1,096,527) (814,151) (843,644) (711,762)
Non-PEO NEO | Year End Fair Value Of Outstanding Equity Awards Granted In Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,988,028 1,058,610 2,282,600 1,712,974
Non-PEO NEO | Change In Fair Value of Outstanding Equity Awards Granted In Prior Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 644,655 (1,380,326) 1,754,107 2,185,114
Non-PEO NEO | Change In Fair Value Of PriorYear Equity Awards Vested In Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 182,705 (365,275) (5,442) 551,610
Non-PEO NEO | Includable Dividends Earnings On Equity Awards During Covered Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 19,277 $ 20,412 $ 16,913 $ 24,815